Pharmalittle: Japan panel nixes Biogen Alzheimer’s drug; Oxfam urges SEC to probe Moderna over patent dispute remarks
Oxfam America has filed a complaint with securities regulators accusing Moderna of providing ‘misleading statements’ and concealing material information about its dispute with the U.S. government over…









